A new study indicates resistance to shorter and less toxic drug regimens for multidrug-resistant tuberculosis (MDR-TB) is ...

Pennsylvania health officials reviewed the case and determined "no public health action is currently necessary," the ...

A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...

Mycobacterium tuberculosis, the causative agent of tuberculosis, produces toxins and their antidotes to regulate its growth ...

Researchers have come up with a new way to identify more infectious variants of viruses or bacteria that start spreading in ...

Tuberculosis (TB) is the world’s biggest infectious disease killer with multidrug-resistant TB (MDR-TB) posing a particular ...

The new WHO-approved MDR-TB treatment BPaL(M) offers hope for tuberculosis patients but is already encountering resistance. A ...

Worldwide, approximately 2 million children younger than 15 years of age are infected with multidrug-resistant (MDR) Mycobacterium tuberculosis, with MDR tuberculosis developing in approximately ...

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of Pittsburgh research published ...

New technologies like wastewater surveillance have enabled public health officials to monitor the spread of infectious ...

A new genetic tool tracks infectious disease variants quickly, guiding better vaccines and antibiotic choices to stop the ...